Eisai
4523.T
#1525
Rank
ยฃ8.79 B
Marketcap
ยฃ31.10
Share price
1.03%
Change (1 day)
-36.19%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2023 (TTM): ยฃ1.80

According to Eisai's latest financial reports the company's current EPS (TTM) is ยฃ1.66. In 2022 the company made an earnings per share (EPS) of ยฃ1.22 a decrease over its 2021 EPS that were of ยฃ5.42.

EPS history for Eisai from 2009 to 2023

Annual EPS

Year EPS Change
2023 (TTM)ยฃ1.8047.62%
2022ยฃ1.22-77.48%
2021ยฃ5.42-41.88%
2020ยฃ9.33-0.94%
2019ยฃ9.4252.59%
2018ยฃ6.17124.17%
2017ยฃ2.75-49.42%
2016ยฃ5.4437.08%
2015ยฃ3.97-11.75%
2014ยฃ4.50-3.23%
2013ยฃ4.65-18.56%
2012ยฃ5.71-15.51%
2011ยฃ6.76-3.75%
2010ยฃ7.02-1.36%
2009ยฃ7.12